Screening pregnant women for autoimmune thyroid disease: A cost-effectiveness analysis

European Journal of Endocrinology

Volumn 158, Issue 6, 2008, Pages 841-851

  Dosiou, Chrysoula ^a   Sanders, Gillian D ^b   Araki, Sally S ^c   Crapo, Lawrence M ^d  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c STANFORD UNIVERSITY   (United States)

^d SANTA CLARA VALLEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; IODIDE PEROXIDASE;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE THYROIDITIS; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HYPOTHYROIDISM; INTELLECTUAL IMPAIRMENT; INTELLIGENCE QUOTIENT; INTERMETHOD COMPARISON; INTRAUTERINE GROWTH RETARDATION; MATERNAL WELFARE; PATIENT COMPLIANCE; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; SCREENING TEST; SENSITIVITY ANALYSIS; STRATEGIC PLANNING; AUTOIMMUNE DISEASE; COST BENEFIT ANALYSIS; ECONOMICS; MASS SCREENING; METABOLISM; METHODOLOGY; MIDDLE AGED; PREGNANCY; STATISTICAL MODEL; THYROID DISEASE;

ADOLESCENT; ADULT; AUTOIMMUNE DISEASES; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; IODIDE PEROXIDASE; MARKOV CHAINS; MASS SCREENING; MIDDLE AGED; MODELS, ECONOMIC; PREGNANCY; PREGNANCY TRIMESTER, FIRST; THYROID DISEASES; THYROTROPIN;

EID: 44949118525     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0882     Document Type: Article

References (54)

1. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA & Braverman LE. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism 2002 87 489-499.
2. Allan WC, Haddow JE, Palomaki GE, Williams JR, Mitchell ML, Hermos Rj, Faix JD & Klein RZ. Maternal thyroid deficiency and pregnancy complications: implications for population screening. Journal of Medical Screening 2000 7 127-130.
3. Klein RZ, Haddow JE, Faix JD, Brown RS, Hermos RJ, Pulkkinen A & Mitchell ML. Prevalence of thyroid deficiency in pregnant women. Clinical Endocrinology 1991 35 41-46.
4. Buckshee K, Kriplani A, Kapil A, Bhargava VL & Takkar D. Hypothyroidism complicating pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology 1992 32 240-242.
5. Davis LE, Leveno KJ & Cunningham FG. Hypothyroidism complicating pregnancy. Obstetrics and Gynecology 1988 72 108-112.
6. Leung AS, Millar LK, Koonings PP, Montoro M & Mestman JH. Perinatal outcome in hypothyroid pregnancies. Obstetrics and Gynecology 1993 81 349-353.
7. Amino N, Tada H, Hidaka Y, Crapo LM & Stagnaro-Green A. Therapeutic controversy: screening for postpartum thyroiditis. Journal of Clinical Endocrinology and Metabolism 1999 84 1813-1821.
8. Gerstein HC. How common is postpartum thyroiditis? A methodologic overview of the literature Archives of Internal Medicine 1990 150 1397-1400.
9. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O'Heir CE, Mitchell ML, Hermos RJ, Waisbren SE, Faix JD & Klein RZ. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. New England Journal of Medicine 1999 341 549-555.
10. Man EB, Brown JF & Serunian SA. Maternal hypothyroxinemia: psychoneurological deficits of progeny. Annals of Clinical and Laboratory Science 1991 21 227-239.
11. Pop VJ, Kuijpens JL, van Baar AL, Verkerk G, van Son MM, de Vijlder JJ, Vulsma T, Wiersinga WM, Drexhage HA & Vader HL. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clinical Endocrinology 1999 50 149-155.
12. Pop VJ, Brouwers EP, Vader HL, Vulsma T, van Baar AL & de Vijlder JJ Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clinical Endocrinology 2003 59 282-288.
13. Morreale de Escobar G, Obregon MJ & Escobar del Rey F. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? Journal of Clinical Endocrinology and Metabolism 2000 85 3975-3987.
14. Klein RZ, Sargent JD, Larsen PR, Waisbren SE, Haddow JE & Mitchell ML. Relation of severity of maternal hypothyroidism to cognitive development of offspring. Journal of Medical Screening 2001 8 18-20.
15. CDC NVSR. Births: Final data for 2002., edn vol 52, Number 10, 2003.
16. Danese MD, Powe NR, Sawin CT & Ladenson PW. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. Journal of the American Medical Association 1996 276 285-292.
17. Bona M, Santini F, Rivolta G, Grossi E & Grilli R. Cost effectiveness of screening for subclinical hypothyroidism in the elderly. A decision-analytical model. PharmacoEconomics 1998 14 209-216.
18. Helfand M. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the US Preventive Services Task Force. Annals of Internal Medicine 2004 140 128-141.
19. Surks MI, Ortiz E, Daniels GH, Sawin CT Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS & Weissman NJ. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. Journal of the American Medical Association 2004 291 228-238.
20. American College of Obstetricians and Gynecologists. Thyroid disease in pregnancy ACOG practice bulletin No. 37. Obstetrics and Gynecology 2002 100 387-396.
21. Gharib H, Cobin RH & Dickey RA. Subclinical hypothyroidism during pregnancy: position statement from the American Association of Clinical Endocrinologists. Endocrine Practice 1999 5 367-368.
22. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA & McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. Journal of Clinical Endocrinology and Metabolism 2005 90 581-585 (discussion 586-587).
23. Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, Mandel SJ & Stagnaro-Green A. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2007 92 S1-S47.
24. Haddow JE, McClain MR, Palomaki GE, Kloza EM & Williams J. Screening for thyroid disorders during pregnancy: results of a survey in Maine. American Journal of Obstetrics and Gynecology 2006 194 471-474.
25. Beck JR & Pauker SG. The Markov process in medical prognosis. Medical Decision Making 1983 3 419-458.
26. Sonnenberg FA & Beck JR. Markov models in medical decision making: a practical guide. Medical Decision Making 1993 13 322-338.
27. Weinstein MC, Siegel JE, Gold MR, Kamlet MS & Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. Journal of the American Medical Association 1996 276 1253-1258.
28. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F & Yaing ET. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clinical Endocrinology 1995 43 55-68.
29. Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ & Cunningham FG. Subclinical hypothyroidism and pregnancy outcomes. Obstetrics and Gynecology 2005 105 239-245.
30. Haddow JE, Knight GJ, Palomaki GE, McClain MR & Pulkkinen AJ. The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy. Journal of Medical Screening 2004 11 170-174.
31. Medicare. Clinical Laboratory Fee Schedule. http://www.ems.hhs.gov/ ClinicalLabFeeSched/02_clinlab.asp, 2004.
32. American Medical Association. Medicare RBRVs: The Physician's Guide Chicago, IL: American Medical Association, 2004.
33. Thompson PDR. Red Book Montvale, NJ: Thompson PDR, 2004.
34. Omu AE, al-Othman S, at-Qattan F, al-Falah FZ & Sharma P. A comparative study of obstetric outcome of patients with pregnancy induced hypertension: economic considerations. Acta Obstetricia et Gynecologica Scandinavica 1996 75 443-448.
35. Bonds DE & Freedberg KA. Cost-effectiveness of prenatal screening for postpartum thyroiditis. Journal of Women's Health and Gender-Based Medicine 2001 10 649-658.
36. Grosse SD, Matte TD, Schwartz J & Jackson RJ. Economic gains resulting from the reduction in children's exposure to lead in the United States. Environmental Health Perspectives 2002 110 563-569.
37. Nolan JP, Tarsa NJ & DiBenedetto G. Case-finding for unsuspected thyroid disease: costs and health benefits. American Journal of Clinical Pathology 1985 83 346-355.
38. Tengs TO & Wallace A. One thousand health-related quality-of-life estimates. Medical Care 2000 38 583-637.
39. Casey BM, Dashe JS, Wells CE, McIntire DD, Leveno KJ & Cunningham FG. Subclinical hyperthyroidism and pregnancy outcomes. Obstetrics and Gynecology 2006 107 337-341.
40. Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydzak CE, Douglass LR, Lazzeroni LC, Holodniy M & Owens DK. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. New England Journal of Medicine 2005 352 570-585.
41. Littenberg B, Garber AM & Sox HC Jr. Screening for hypertension. Annals of Internal Medicine 1990 112 192-202.
42. Premawardhana LD, Parkes AB, Ammari F, John R, Darke C, Adams H & Lazarus JH. Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity. Journal of Clinical Endocrinology and Metabolism 2000 85 71-75.
43. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D & Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. Journal of Clinical Endocrinology and Metabolism 2006 91 2587-2591.
44. Lazarus JH, Parkes AB, Taylor IL, Smyth PPA, John R & Wald N. Controlled antenatal thyroid screening study (CATS) - Presented at the British Endocrine Societies Joint Meeting: Brighton, UK. Endocrine Abstracts 2004 7 243.
45. National Institute of Child Health and Human Development. http://www.clinicaltrials.gov/ct/show/NCT00388297;jsessionid BF64497FA0B249A88F223EA, 2007.
46. Auso E, Lavado-Autric R, Cuevas E, Del Rey FE, Morreale De Escobar G & Berbel P. A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. Endocrinology 2004 145 4037-4047.
47. Friesema EC, Grueters A, Biebermann H, Krude H, von Moers A, Reeser M, Barrett TG, Mancilla EE, Svensson J, Kester MH, Kuiper GG, Balkassmi S, Uitterlinden AG, Koehrle J, Rodien P, Halestrap AP & Visser TJ. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 2004 364 1435-1437.
48. Lavado-Autric R, Auso E, Garcia-Velasco JV, Arufe Mdel C, Escobar del Rey F, Berbel P & Morreale de Escobar G. Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. Journal of Clinical Investigation 2003 111 1073-1082.
49. Vaidya B, Anthony S, Bilous M, Shields B, Drury J, Hutchison S & Bilous R. Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding? Journal of Clinical Endocrinology and Metabolism 2007 92 203-207.
50. Engler H, Riesen WF & Keller B. Anti-thyroid peroxidase (anti-TPO) antibodies in thyroid diseases, non-thyroidal illness and controls. Clinical validity of a new commercial method for detection of anti-TPO (thyroid microsomal) autoantibodies. Clinica Chimica Acta 1994 225 123-136.
51. Gilmour J, Brownlee Y, Foster P, Geekie C, Kelly P, Robertson S, Wade E, Braun HB, Staub U, Michel G, Lazarus JH & Parkes AB. The quantitative measurement of autoantibodies to thyroglobulin and thyroid peroxidase by automated microparticle based immunoassays in Hashimoto's disease, Graves' disease and a follow-up study on postpartum thyroid disease. Clinical Laboratory 2000 46 57-61.
52. Mariotti S, Caturegli P, Piccolo P, Barbesino G & Pinchera A. Antithyroid peroxidase autoantibodies in thyroid diseases. Journal of Clinical Endocrinology and Metabolism 1990 71 661-669.
53. Hall J, Gerard K, Salkeld G & Richardson J. A cost utility analysis of mammography screening in Australia. Social Science and Medicine 1992 34 993-1004.
54. Whynes DK, Neilson AR. Walker AR & Hardcastle JD. Faecal occult blood screening for colorectal cancer: is it cost-effective? Health Economies 1998 7 21-29.